NSE:NECLIFE (India)
Â
Shs Dematerialised
₹
12.31
+0.18 (+1.48%)
Sep 2
Business Description
Nectar Lifesciences Ltd
ISIN : INE023H01027
Share Class Description:
NSE:NECLIFE: Shs DematerialisedTotal Employee Number:
1,786Compare
Compare
Traded in other countries / regions
532649.India IPO Date
2005-07-18Description
Nectar Lifesciences Ltd, an India-based pharmaceutical company, was previously engaged in the manufacture and sale of pharmaceutical products, including active pharmaceutical ingredients (APIs), formulations, menthol, and empty hard gelatin capsules. Recently, it has undertaken some restructuring and asset monetization initiatives, including a slump sale/business transfer arrangement of its key business units. Additionally, the company is currently evaluating various opportunities and projects to pursue its newly adopted objectives and expand its presence in the real estate business.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.79 | |||||
Debt-to-EBITDA | 40.65 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 23.2 | |||||
3-Year Book Growth Rate | -14.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.92 | |||||
9-Day RSI | 59.71 | |||||
14-Day RSI | 59.32 | |||||
3-1 Month Momentum % | -11.91 | |||||
6-1 Month Momentum % | -8.87 | |||||
12-1 Month Momentum % | -27.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.4 | |||||
Quick Ratio | 8.39 | |||||
Cash Ratio | 4.15 | |||||
Days Inventory | 25048.6 | |||||
Days Sales Outstanding | 14559.68 | |||||
Days Payable | 23864.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 4.7 | |||||
Shareholder Yield % | 60.57 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.79 | |||||
Operating Margin % | -1740.53 | |||||
Net Margin % | -1384.56 | |||||
EBITDA Margin % | 225.26 | |||||
FCF Margin % | -8558.56 | |||||
OCF Margin % | -8328.55 | |||||
ROE % | -9.23 | |||||
ROA % | -4.64 | |||||
3-Year ROIIC % | 1.21 | |||||
ROC (Joel Greenblatt) % | 2.22 | |||||
ROCE % | 1.38 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 53.85 | |||||
PB Ratio | 0.41 | |||||
Price-to-Tangible-Book | 0.41 | |||||
EV-to-EBIT | 10.47 | |||||
EV-to-EBITDA | 10.03 | |||||
EV-to-Revenue | 22.61 | |||||
EV-to-FCF | -0.27 | |||||
Price-to-GF-Value | 1.79 | |||||
Price-to-Projected-FCF | 0.31 | |||||
| Price-to-Net-Current-Asset-Value | 1.12 | |||||
| Price-to-Net-Cash | 2.79 | |||||
Earnings Yield (Greenblatt) % | 9.55 | |||||
FCF Yield % | -179.93 | |||||
Forward Rate of Return (Yacktman) % | 34.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nectar Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 50.111 | ||
| EPS (TTM) (₹) | -11.38 | ||
| Beta | 1.8544 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.51 | ||
| Volatility % | 61.95 | ||
| 14-Day RSI | 59.32 | ||
| 14-Day ATR (₹) | 0.613269 | ||
| 20-Day SMA (₹) | 11.191 | ||
| 12-1 Month Momentum % | -27.19 | ||
| 52-Week Range (₹) | 9.3 - 22.4 | ||
| Shares Outstanding (Mil) | 194.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nectar Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nectar Lifesciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 10:1 Stock Split | 2008-11-12 | 20.13 (-4.17%) |
Show
Entries
Nectar Lifesciences Ltd Frequently Asked Questions
What is Nectar Lifesciences Ltd(NSE:NECLIFE)'s stock price today?
The current price of NSE:NECLIFE is ₹12.31. The 52 week high of NSE:NECLIFE is ₹22.40 and 52 week low is ₹9.30.
When is next earnings date of Nectar Lifesciences Ltd(NSE:NECLIFE)?
The next earnings date of Nectar Lifesciences Ltd(NSE:NECLIFE) is .
Does Nectar Lifesciences Ltd(NSE:NECLIFE) pay dividends? If so, how much?
Nectar Lifesciences Ltd(NSE:NECLIFE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nectar Lifesciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers